Goldman, Sachs

Goldman Sachs Shares Surge to New Peak on M&A Optimism

10.12.2025 - 21:42:04 | boerse-global.de

Marcus US5663301068

Goldman Sachs Shares Surge to New Peak on M&A Optimism - Foto: über boerse-global.de

Shares of Goldman Sachs Group Inc. reached a fresh 52-week high this week, propelled by a bullish internal forecast for mergers and acquisitions and the unveiling of new strategic plans. The stock price climbed to $893.56 on Wednesday before closing the session at $892.13, marking a gain of 1.77%.

The equity's advance followed a presentation by Chief Financial Officer Denis Coleman, who projected that 2026 could become the second-strongest year on record for global M&A activity. He pointed to a notable increase in deal-making already underway, citing 63 "mega-deals" valued above $10 billion each that had been announced by the end of November 2025.

This optimistic outlook from the bank's own finance chief appears to be reinforcing positive sentiment among market participants. Analysts have recently echoed this confidence; Bank of America, for instance, raised its price target for Goldman Sachs to $900, highlighting the firm's advantageous positioning within a recovering capital markets landscape.

Strategic Moves to Fuel Growth

Concurrent with this forecast, the firm is pushing forward with strategic initiatives designed to bolster efficiency and expansion. Internally, Goldman Sachs introduced "OneGS 3.0," a company-wide program focused on leveraging artificial intelligence to enhance productivity across its operations. Despite previous efficiency measures, the bank anticipates a net increase in its headcount for 2025 to support this expected growth phase.

Should investors sell immediately? Or is it worth buying Marcus?

Externally, its asset management arm is broadening its European footprint. Goldman Sachs Asset Management (GSAM) recently launched three new actively managed bond ETFs, which are now listed on the Deutsche Börse. This expansion brings its total offering to eight such products, aiming to meet rising investor demand for transparent, active fixed-income strategies.

Technical Momentum and Upcoming Catalyst

From a technical perspective, the breakout to new highs confirms the upward momentum previously identified by market experts. Analysts suggest the bullish trend remains intact as long as the share price holds above the prior resistance level of $885.

Investor attention is now firmly set on January 15, 2026, the anticipated date for Goldman Sachs's release of its annual and quarterly financial results. The market will be scrutinizing whether the predicted surge in M&A activity translates immediately into advisory fee revenue, or if the significant revenue impact will materialize later in the second half of 2026. The coming earnings report will serve as a critical test for the CFO's promising forecast.

Ad

Marcus Stock: Buy or Sell?! New Marcus Analysis from December 10 delivers the answer:

The latest Marcus figures speak for themselves: Urgent action needed for Marcus investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 10.

Marcus: Buy or sell? Read more here...

So schätzen die Börsenprofis Goldman Aktien ein!

<b>So schätzen die Börsenprofis  Goldman Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
US5663301068 | GOLDMAN | boerse | 68416327 |

Weitere Meldungen

ANALYSE-FLASH: Goldman senkt Ziel für Henkel auf 70 Euro - 'Sell' Die US-Investmentbank Goldman Sachs hat das Kursziel für Henkel DE0006048432 vor Quartalszahlen von 73 auf 70 Euro gesenkt und die Einstufung auf "Sell" belassen. (Boerse, 02.04.2026 - 12:35) weiterlesen...

ANALYSE-FLASH: Goldman hebt Ziel für Evonik auf 20 Euro - 'Buy' Die US-Investmentbank Goldman Sachs hat das Kursziel für Evonik DE000EVNK013 vor Quartalszahlen von 18 auf 20 Euro angehoben und die Einstufung auf "Buy" belassen. (Boerse, 02.04.2026 - 11:20) weiterlesen...

ANALYSE-FLASH: Goldman hebt Rheinmetall auf 'European Conviction List' - 'Buy' Die US-Investmentbank Goldman Sachs hat die Rheinmetall-Aktie DE0007030009 in die "European Conviction List" für besonders aussichtsreiche Werte aufgenommen. (Boerse, 01.04.2026 - 19:05) weiterlesen...

AKTIE IM FOKUS: Goldman Sachs treibt kräftige Rheinmetall-Erholung voran Die Aktie von Rheinmetall DE0007030009 hat sich am Mittwoch im freundlichen Gesamtmarkt weiter von ihrem am Montag erreichten Elf-Monats-Tief nach oben hin abgesetzt. (Boerse, 01.04.2026 - 16:51) weiterlesen...

ANALYSE-FLASH: Goldman senkt Ziel für Lanxess auf 21 Euro - 'Neutral' Die US-Investmentbank Goldman Sachs hat das Kursziel für Lanxess DE0005470405 vor Zahlen zum ersten Quartal von 23 auf 21 Euro gesenkt und die Einstufung auf "Neutral" belassen. (Boerse, 01.04.2026 - 12:34) weiterlesen...

ANALYSE-FLASH: Goldman hebt Sartorius Stedim Biotech auf 'Buy' - Ziel gesenkt Die US-Investmentbank Goldman Sachs hat das Kursziel für Sartorius Stedim FR0013154002 von 235 auf 214 Euro gesenkt, die Aktien aber von "Neutral" auf "Buy" hochgestuft. (Boerse, 30.03.2026 - 09:04) weiterlesen...